People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,170.00GBp
28 Jul 2015
Change (% chg)

-20.50p (-0.49%)
Prev Close
4,190.50p
Open
4,208.50p
Day's High
4,218.00p
Day's Low
4,137.00p
Volume
2,965,527
Avg. Vol
2,505,857
52-wk High
4,931.68p
52-wk Low
4,019.00p

Search Stocks

Burlington, Bruce 

Dr. Bruce Burlington is Non-Executive Independent Director of AstraZeneca Plc. Bruce is a pharmaceutical product development and regulatory affairs consultant and brings experience in those areas to the Board. He is a pharmaceutical product development and regulatory affairs consultant and brings extensive experience in those areas. He spent 17 years with the FDA, serving as Director of its Center for Devices and Radiological Health as well as holding various senior roles in the Center for Drug Evaluation and Research. After leaving the FDA, he held various senior executive positions at Wyeth (now part of Pfizer). Other Appointments Bruce is a Non-Executive Director of the International Partnership for Microbicides, and a member of the scientific advisory boards of the International Medica Foundation and H. Lundbeck A/S.

Basic Compensation

Total Annual Compensation, GBP 105,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 105,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

572,000

Pascal Soriot

3,507,000

Marc Dunoyer

1,921,000

Fiona Cicconi

--

Ruud Dobber

--

Paul Hudson

--
As Of  30 Dec 2014
Search Stocks